1

International Isotopes

International Isotopes
Leadership team

Mr. Stephen T. Laflin (Pres, CEO & Director)

Mr. W. Matthew Cox B.S., CPA (CFO & Sec.)

Products/ Services
Customer Service, Health Care, Manufacturing
Number of Employees
0 - 50
Headquarters
Idaho Falls, Idaho, United States
Established
1995
Company Registration
SEC CIK number: 0001038277
Revenue
5M - 20M
Traded as
OTCQB:INIS
Overview
Location
Summary
International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Radiological Services segment provides flood source disposal and gemstones processing services. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. It sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.
History

International Isotopes Inc. was established in 1992 with the purpose of providing quality services and products in the field of nuclear medicine. Since that time, the company has become a leader in the manufacturing, marketing, and distribution of radioisotopes, radiopharmaceuticals, and nuclear medicine calibration and reference sources around the world. The company's products are used for medical, dental, veterinary, medical research, government, and academic activities.

Mission
At International Isotopes, our mission is to provide the highest quality products and services through innovative products, superior customer service, on time delivery and value pricing.
Vision
To be the premier provider of high quality products and services that enable and support nuclear medicine, medicine, and research.
Key Team

Mr. W. Matthew Cox B.S., CPA (CFO & Sec.)

Mr. Stephen T. Laflin (Pres, CEO & Director)

Recognition and Awards
International Isotopes is the recipient of numerous awards and honors including the B. Everett Jordan Award for Excellence in Quality, the Malcolm Baldrige Quality Award of Excellence, and the International Quality Grand Prize Award.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

International Isotopes
Leadership team

Mr. Stephen T. Laflin (Pres, CEO & Director)

Mr. W. Matthew Cox B.S., CPA (CFO & Sec.)

Products/ Services
Customer Service, Health Care, Manufacturing
Number of Employees
0 - 50
Headquarters
Idaho Falls, Idaho, United States
Established
1995
Company Registration
SEC CIK number: 0001038277
Revenue
5M - 20M
Traded as
OTCQB:INIS